Terms ending in 2042
Every in-force patent on Exosome Diagnostics, Inc.'s record whose computed term ends in 2042, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,258,587 | Compositions and Methods for Internal Controls of Microvesicle Isolations In force · High confidence | Exact Sciences Corporation | In force | High confidence | |
| US 12,378,608 | Methods for Developing Urine Biomarkers and for Detecting Bladder Cancer In force · High confidence | Exosome Diagnostics, Inc. | In force | High confidence |
2 of 2 patents shown. Soonest term end first, then patent number.
1 of these is in force and held by Exosome Diagnostics, Inc..
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.